title: Antiplatelet therapy and platelet function testing. Introduction.
authors.affiliation: TIMI Study Group, Cardiovascular Division, Brigham and Women's Hospital, Department of Medicine, Harvard Medical School, 350 Longwood Avenue, Boston, Massachusetts 02115, USA. ebraunwald@partners.org
authors.forename: Eugene
authors.initials: E
authors.lastname: Braunwald
authors.forename: Dominick
authors.initials: D
authors.lastname: Angiolillo
authors.forename: Eric
authors.initials: E
authors.lastname: Bates
authors.forename: Peter B
authors.initials: PB
authors.lastname: Berger
authors.forename: Deepak
authors.initials: D
authors.lastname: Bhatt
authors.forename: Christopher P
authors.initials: CP
authors.lastname: Cannon
authors.forename: Mark I
authors.initials: MI
authors.lastname: Furman
authors.forename: Paul
authors.initials: P
authors.lastname: Gurbel
authors.forename: Alan D
authors.initials: AD
authors.lastname: Michelson
authors.forename: Eric
authors.initials: E
authors.lastname: Peterson
authors.forename: Stephen
authors.initials: S
authors.lastname: Wiviott
mesh_terms: D054058:Acute Coronary Syndrome / Q000097:blood / Q000628:therapy*; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects*; D001792:Blood Platelets / Q000187:drug effects*; D004351:Drug Resistance; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D010979:Platelet Function Tests; D013927:Thrombosis / Q000097:blood / Q000209:etiology / Q000517:prevention & control*
chemical_list: D010975:Platelet Aggregation Inhibitors